WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2007014008) BENZENESULFONAMIDE INHIBITOR OF CCR2 CHEMOKINE RECEPTOR
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2007/014008    International Application No.:    PCT/US2006/028321
Publication Date: 01.02.2007 International Filing Date: 21.07.2006
IPC:
C07D 401/02 (2006.01), A61K 31/44 (2006.01)
Applicants: GLAXO GROUP LIMTED [GB/GB]; GLAXO WELLCOME HOUSE, Berkeley Ave, Greenford, Middlesex, UB6 0NN (GB) (For All Designated States Except US).
BROOKS, Carl [GB/US]; (US) (For US Only).
PEACE, Simon [GB/GB]; (GB) (For US Only).
SMETHURST, Christian [GB/GB]; (GB) (For US Only).
WATSON, Stephen, Paul [GB/GB]; (GB) (For US Only)
Inventors: BROOKS, Carl; (US).
PEACE, Simon; (GB).
SMETHURST, Christian; (GB).
WATSON, Stephen, Paul; (GB)
Agent: WILLIS, Reid, S.; GLAXOSMITHKLINE, CORPORATE INTELLECTUAL PROPERTY, UW2220, 709 Swedeland Road, P.o. Box 1539, King Of Prussia, PA 19406-0939 (US)
Priority Data:
0515195.6 22.07.2005 GB
0525240.8 12.12.2005 GB
Title (EN) BENZENESULFONAMIDE INHIBITOR OF CCR2 CHEMOKINE RECEPTOR
(FR) INHIBITEUR BENZENESULFONAMIDE DE RECEPTEUR DE CHIMIOKINE CCR2
Abstract: front page image
(EN)The present invention is related to a compound of formula (I) or a salt thereof, or a solvate thereof, or a combination thereof. The present invention also includes a compositions including the compound of Formula I as well as a method of treating disorders mediated by the CCR2 receptor with the compound of Formula I.
(FR)L'invention concerne un composé de formule (I) ou un sel, un solvate, ou une combinaison de celui-ci. Cette invention concerne également une composition contenant le composé de formule (I) ainsi qu'un procédé de traitement des troubles induits par le récepteur CCR2 au moyen du composé de formule (I).
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LV, LY, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)